Context
Retinoblastoma is one of the most common childhood cancer tumours. It can be treated particularly well, provided it is diagnosed in time. However, the visual prognosis can be compromised depending on the location of the tumour and the impact of treatment on the retina.
Supported project
In 2020-2021, L'OCCITANE Manosque and the Foundation supported the Institut Curie in its project to combat retinoblastoma in children.
The project aimed to create preclinical models of ocular tumors (retinoblastoma and uveal melanoma) on rats. Before moving on to clinical trials on humans, preclinical animal models are needed to test new treatments. The rat is a good model in ophthalmology research as its eyes are large enough to perform transplants of tumor cells from patients. The creation of two preclinical models of retinoblastoma and uveal melanoma made it possible to test new treatments with the aim of maintaining the patient's eye as well as maximum visual acuity.
Some figures
Budget 10 000 euros
Results 155 beneficiaries
Partnership history
Project supported since 2018
L'OCCITANE Manosque and the Foundation have supported the Institut Curie in its project to combat retinoblastoma in children since 2018.